Consistent with our results, high levels of HK2 expression are significantly associated with an aggressive phenotype in patients with primary diffuse large B-cell lymphoma (DLBCL), suggesting that HK2 level could be used to stratify DLBCL patients31. Here, HK2 is linked to diffuse large B-cell lymphoma.